| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Elicio Therapeutics, Inc. (ELTX) has 2 insiders with recent SEC Form 4 filings, including 0 buys and 6 sells. ELTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 57.4K | $180.2K | - | |
| Other | 743 | $2.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2021 | Rhodes Jennifer J93 | See Remarks | Sell | 399 | $15.01 | $5,988.99 | -1.2% | -28.3% | -88.4% | |
| Mar 17, 2021 | Neylan John F.95 | See Remarks | Sell | 442 | $19.13 | $8,455.46 | -1.1% | -30.8% | -88.3% | |
| Mar 13, 2021 | Rhodes Jennifer J93 | See Remarks | Sell | 499 | $20.45 | $10,204.55 | -1.4% | -35.5% | -91.7% | |
| Feb 13, 2021 | Rhodes Jennifer J93 | See Remarks | Sell | 457 | $19.54 | $8,929.78 | -1.3% | - | - | |
| Feb 9, 2021 | Venkatesan Jay | See Remarks | Sell | 159,177 | $16.00 | $2,546,832.00 | -11.6% | - | - | |
| Feb 9, 2021 | Ganzi Victor F84 | Director | Sell | 246,720 | $16.00 | $3,947,520.00 | -30.0% | - | - |